Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Retained Earnings (2016 - 2025)

Arrowhead Pharmaceuticals' Retained Earnings history spans 16 years, with the latest figure at -$1.6 billion for Q4 2025.

  • For Q4 2025, Retained Earnings fell 38686.97% year-over-year to -$1.6 billion; the TTM value through Dec 2025 reached -$1.6 billion, down 38686.97%, while the annual FY2025 figure was -$1.6 billion, 34355.87% down from the prior year.
  • Retained Earnings reached -$1.6 billion in Q4 2025 per ARWR's latest filing, up from -$1.6 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $4.8 million in Q3 2024 to a low of -$1.6 billion in Q3 2025.
  • Average Retained Earnings over 5 years is -$755.9 million, with a median of -$774.3 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: crashed 1185977.42% in 2022, then surged 100.46% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$707.6 million in 2021, then fell by 21.84% to -$862.1 million in 2022, then crashed by 34.43% to -$1.2 billion in 2023, then soared by 100.36% to $4.1 million in 2024, then plummeted by 38686.97% to -$1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Retained Earnings are -$1.6 billion (Q4 2025), -$1.6 billion (Q3 2025), and -$1.6 billion (Q2 2025).